Risk of major structural birth defects following repeat mRNA COVID-19 vaccination in the first trimester: a population-based cohort study
Clinical Microbiology and Infection · 2026-08 · 32 (8) · 1302-1310
DOI: 10.1016/j.cmi.2026.03.027 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Microbiology and Infection, 2026-08. Verfasst von Liang En Wee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Communicable Diseases Agency, Singapore; Duke-NUS Graduate Medical School, National University of Singapore, Singapore; Department of Infectious Dise…. Hauptthemen laut MEDLINE: COVID-19 Vaccines, Congenital Abnormalities, COVID-19. Die Arbeit nennt 30 Literaturangaben. Gefördert von: National Medical Research Council, Government of Singapore Ministry of Health.
Abstract (Originalsprache)
OBJECTIVES Vaccine safety concerns (e.g. foetal health) underpin maternal vaccine hesitancy during COVID-19 endemicity; although substantial real-world evidence highlights absence of increased risk for foetal abnormalities following one dose of COVID-19 vaccination during the first trimester, risk following repeat vaccination was not explicitly assessed. Risk of major structural birth defects following revaccination of previously vaccinated mothers with mRNA COVID-19 vaccine doses in the first trimester was assessed using national vaccination registers and healthcare claims databases. METHODS A population-based cohort study was performed including all infants born to Singaporean mothers (citizens/permanent residents) aged 18-50 years who had previously received ≥1 vaccine dose, with a last menstrual period from 1 July 2021 to 31 December 2023. Exposure (vaccination) was determined using the National Immunisation Registry; outcomes (birth defects) were determined using national healthcare claims data. Risk of major structural birth defects following repeat vaccination (first trimester) was estimated using generalized Poisson regression with robust standard errors and overlap weights applied. RESULTS A total of 47 665 live births were included in the final cohort. One-tenth (11.2%, 5327 of 47 665) had repeat maternal COVID-19 vaccination (mRNA vaccine doses) during the first trimester, of which 9.9% (527 of 5327) comprised bivalent formulations. Risk of a major structural birth defect was not significantly increased (adjusted prevalence ratio [aPR], 0.97; 95% CI, 0.74-1.27) following repeat vaccination in the first trimester, versus no vaccination (first trimester). No significantly elevated risk of major structural birth defect was observed following repeat vaccination with bivalent formulations (aPR, 0.45; 95% CI, 0.14-1.39) or ancestral vaccines (aPR, 1.04; 95% CI, 0.79-1.36), although CIs were wide. CONCLUSIONS Repeat vaccination with mRNA COVID-19 vaccines in the first trimester was not significantly associated with increased risk for major structural birth defects, underlining safety of maternal revaccination with seasonally updated COVID-19 booster doses during endemicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Communicable Diseases Agency, Singapore; Duke-NUS Graduate Medical School, National University of Singapore, Singapore; Department of Infectious Diseases, Singapore General Hospital, Singapore; Lee Kong Chian School of…
- Communicable Diseases Agency, Singapore; National Centre for Infectious Diseases, Singapore.
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
- Duke-NUS Graduate Medical School, National University of Singapore, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Infectious Disease Service, Department of Pediatrics, KK Wom…
- Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Obstetrics and Gynaecology, National University Centre for Women and Children (NUWoC)…
- Communicable Diseases Agency, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; National Centre for Infectious Diseases, Singapore; Yong Loo Lin School of Medicine, National Univ…
Förderung
- National Medical Research Council
- Government of Singapore Ministry of Health
Zitieren
APA
Wee, L. E., Bin Abdul Malek, M. I., Ho, R. W., Lim, J. T., Chiew, C., Li, R. J., Chong, C. Y., Choolani, M., Lye, D., & Tan, K. B. (2026). Risk of major structural birth defects following repeat mRNA COVID-19 vaccination in the first trimester: a population-based cohort study. Clinical Microbiology and Infection, 32(8), 1302-1310. https://doi.org/10.1016/j.cmi.2026.03.027
Vancouver
Wee LE, Bin Abdul Malek MI, Ho RW, Lim JT, Chiew C, Li RJ, et al. Risk of major structural birth defects following repeat mRNA COVID-19 vaccination in the first trimester: a population-based cohort study. Clinical Microbiology and Infection. 2026;32(8):1302-1310. doi:10.1016/j.cmi.2026.03.027
BibTeX
@article{Wee2026,
author = {Wee, Liang En and Bin Abdul Malek, Muhammad Ismail and Ho, Reen Wl and Lim, Jue Tao and Chiew, Calvin and Li, Russell Jx and Chong, Chia Yin and Choolani, Mahesh and Lye, David and Tan, Kelvin B},
title = {Risk of major structural birth defects following repeat mRNA COVID-19 vaccination in the first trimester: a population-based cohort study},
journal = {Clinical Microbiology and Infection},
year = {2026},
volume = {32},
number = {8},
pages = {1302--1310},
doi = {10.1016/j.cmi.2026.03.027}
}
EUVIMED